NCT05952557 · Interventional trial
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Overall registry status Active not recruiting
Phase 3
Conditions Breast Cancer, Early Breast Cancer
Delaware Valley sites
- Research Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory